RA Capital Management »

Equillium shares owned by RA Capital Management

Quarter-by-quarter ownership of Equillium (EQ) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Equillium

Tip: Access up to 7 years of quarterly data

All positions including Equillium held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Equillium by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $6.2M 3.1M 2.00

More positions owned by RA Capital Management

Ascendis Pharma A/s - Sponsored Adr (ASND)
Vaxcyte Common Stock (PCVX)
Rhythm Pharmaceuticals Common Stock (RYTM)
Tyra Biosciences Common Stock (TYRA)
Sionna Therapeutics Common Stock (SION)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Nuvalent Inc-a Common Stock (NUVL)
Dianthus Therapeutics Common Stock (DNTH)
Mineralys Therapeutics Common Stock (MLYS)
Spyglass Pharma Common Stock
Wave Life Sciences Common Stock (WVE)
Septerna Common Stock (SEPN)
Disc Medicine Common Stock (IRON)
Janux Therapeutics Common Stock (JANX)

View all positions for RA Capital Management

Top funds holding Equillium

Henderson Group
Adage Capital Partners GP
Decheng Capital
ADAR1 Capital Management
Woodline Partners
Standard Life Aberdeen
RA Capital Management
Vanguard Group
Vanguard Capital Management
Balyasny Asset Management
Renaissance Technologies
Hudson Bay Capital Management
Geode Capital Management
Diadema Partners
Ikarian Capital

View all funds holding Equillium